Long-term follow-up of the Stockholm randomized trials of postoperative radiation therapy versus adjuvant chemotherapy among ‘high risk’ pre- and postmenopausal breast cancer patients

References

• Fisher B, Carbone P, Economou S G, et al. l-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. N Engl J Med 1975; 292: 117–22
   PubMed Web of Science ®Google Scholar
• Bonadonna G, Brusamolino E, Valagussa P, et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 1976; 294: 405–10
   PubMed Web of Science ®Google Scholar
• Rutqvist LE, Cedermark B, Glas U, et al. Radiation therapy, chemotherapy and tamoxifen as adjuncts to surgery in early breast cancer: A summary of three randomized trials. Int J Radiat Oncol Biol Phys 1989; 16: 629–39
   PubMed Web of Science ®Google Scholar
• Wrange Ö, Nordenskjöld B, Silfverswärd C, Granberg P-O, Gustafsson J-Å. Isoelectric focusing of estradiol receptor protein from human mammary carcinoma. A comparison to sucrose gradient analysis. Eur J Cancer 1976; 12: 695–700
   PubMed Web of Science ®Google Scholar
• Wrange Ö, Nordenskjöld B, Gustafsson J-Å. Cytosol estradiol receptor in human mammary carcinoma. An assay based on isoelectric focusing in polyacrylamide gel. Anal Biochem 1978; 85: 416–21
   Web of Science ®Google Scholar
• Fernö M, Borg Å, Norgren A. A comparison of two steroid receptor assays in breast cancer: Dextran-coated charcoal and isoelectric focusing. Anticancer Res 1983; 3: 243–6
   PubMed Web of Science ®Google Scholar
• Fernö M, Borg Å, Sellberg G. Enzyme immuno assay of estrogen receptor (ER) in breast cancer biopsy samples. A comparison with isoelectric focusing and detection of ER during tamoxifen treatment. Acta Radiol Oncol 1986; 25: 171–5
   PubMed Web of Science ®Google Scholar
• Burton KA. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of DNA. Biochem J 1956; 62: 315–22
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists′ Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. N Engl J Med 1988; 319: 1681–92
   PubMed Web of Science ®Google Scholar
• Bonadonna G, Brusamolino E, Valagussa P, et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 1976; 294: 405–10
   PubMed Web of Science ®Google Scholar
• Rutqvist LE, Cedermark B, Glas U, Johansson H, Rotstein S, et al. Randomized trial of adjuvant tamoxifen combined with postoperative radiation therapy or adjuvant chemotherapy in postmenopausal breast cancer. Cancer 1990; 66: 89–96
   PubMed Web of Science ®Google Scholar
• Swedish Breast Cancer Cooperative Group. Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. J Natl Cancer Inst 1996; 88: 1543–9
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81
   Web of Science ®Google Scholar
• Marubini E, Valsecchi MG. Competing risks. Statistics in practice: Analysing survival data from clinical trials and observational studies, V Barnett. John Wiley and Sons, Chichester 1995; 331–63
   Google Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719–48
   PubMed Web of Science ®Google Scholar
• Cox DR. Regression models and life tables. J Roy Stat Soc B 1972; 34: 187–220
   Web of Science ®Google Scholar
• Cuzick J, Stewart H, Rutqvist LE, Houghton J, Edwards R, Redmond C, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994; 12: 447–53
   PubMed Web of Science ®Google Scholar
• Rutqvist LE, Fornander T, Lax I, Johansson H. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys 1992; 22: 887–96
   PubMed Web of Science ®Google Scholar
• Deutsch M, Land SR, Begovic M, Wieand HS, Wolmark N, Fisher B. The incidence of lung carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06. Cancer 2003; 98: 1362–8
   PubMed Web of Science ®Google Scholar
• Ford MB, Sigurdson AJ, Petruliss ES, Ng CS, Kemp B, Cooksley C, et al. Effects of smoking and radiotherapy on lung carcinoma in breast cancer survivors. Cancer 2003; 98: 1457–64
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialist′s Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women. Lancet 1992; 339: 1–15, 71–85
   Google Scholar
• Early Breast Cancer Trialist′s Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomized trials. Lancet 2000; 355: 1757–70
   PubMed Web of Science ®Google Scholar
• Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group Trial 82b Trial. N Engl J Med 1997; 337: 949–55
   PubMed Web of Science ®Google Scholar
• Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen. Danish Breast Cancer Cooperative Group Trial 82c Trial. Lancet 1999; 353: 1641–8
   PubMed Web of Science ®Google Scholar
• Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997; 337: 956–62
   PubMed Web of Science ®Google Scholar
• Whelan TJ, Julian J, Wright J, Jadad AR, Levine ML. Does loco-regional radiation therapy improve survival? A meta-analysis. J Clin Oncol 2000; 18: 1220–9
   PubMed Web of Science ®Google Scholar
• Albain, K, Green, S, Ravdin, P, Cobau, C, Levine, E, Ingle, J. Adjuvant chemohormonal therapy for primary breast cancer should be sequential instead of concurrent: Initial results from intergroup trial 0100 (SWOG-8814). In:. M Perry, et al, editor. Thirty-Eighth Annual Meeting of American Society of Clinical Oncology. Am Soc Clin Onc. 2002;36a, abstract 143.
   Google Scholar
• Pico C, Martin M, Jara C, Barnadas A, Pelegri A, et al. Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: Randomized phase II trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 study. Ann Oncol 2004; 15: 79–87
   PubMed Web of Science ®Google Scholar